AMGEN, INC. for AMGEN INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Trans-Pacific Partnership (12 years data exclusivity) Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| L NICOLE CURRIE | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| PAUL NEUREITER | — |
| WILLIAM O'BRIEN | — |
| GREGORY PORTNER | — |
| HELEN RHEE | — |
Health Issues HCR
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| L NICOLE CURRIE | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| NANCY ELLEN MCCARTHY | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| GREGORY PORTNER | — |
| HELEN RHEE | — |
Taxation/Internal Revenue Code TAX
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| L NICOLE CURRIE | — |
| NANCY ELLEN MCCARTHY | — |
| HELEN RHEE | — |
Medicare/Medicaid MMM
Medicare Part B (Average Sales Price) (Medicare Program Part B Drug Payment Model proposed rule)
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| L NICOLE CURRIE | — |
| RUTH HOFFMAN | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| GREGORY PORTNER | — |
| HELEN RHEE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.